Cargando…

Magnetic resonance-based radiomics nomogram for predicting microsatellite instability status in endometrial cancer

BACKGROUND: Microsatellite instability (MSI) status is an important indicator for screening patients with endometrial cancer (EC) who have potential Lynch syndrome (LS) and may benefit from immunotherapy. This study aimed to develop a magnetic resonance imaging (MRI)-based radiomics nomogram for the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Zijing, Wang, Ting, Li, Haiming, Xiao, Meiling, Ma, Xiaoliang, Gu, Yajia, Qiang, Jinwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816750/
https://www.ncbi.nlm.nih.gov/pubmed/36620141
http://dx.doi.org/10.21037/qims-22-255
_version_ 1784864608141443072
author Lin, Zijing
Wang, Ting
Li, Haiming
Xiao, Meiling
Ma, Xiaoliang
Gu, Yajia
Qiang, Jinwei
author_facet Lin, Zijing
Wang, Ting
Li, Haiming
Xiao, Meiling
Ma, Xiaoliang
Gu, Yajia
Qiang, Jinwei
author_sort Lin, Zijing
collection PubMed
description BACKGROUND: Microsatellite instability (MSI) status is an important indicator for screening patients with endometrial cancer (EC) who have potential Lynch syndrome (LS) and may benefit from immunotherapy. This study aimed to develop a magnetic resonance imaging (MRI)-based radiomics nomogram for the prediction of MSI status in EC. METHODS: A total of 296 patients with histopathologically diagnosed EC were enrolled, and their MSI status was determined using immunohistochemical (IHC) analysis. Patients were randomly divided into the training cohort (n=236) and the validation cohort (n=60) at a ratio of 8:2. To predict the MSI status in EC, the tumor radiomics features were extracted from T2-weighted images and contrast-enhanced T1-weighted images, which in turn were selected using one-way analysis of variance (ANOVA) and the least absolute shrinkage and selection operator (LASSO) algorithm to build the radiomics signature (radiomics score; radscore) model. Five clinicopathologic characteristics were used to construct a clinicopathologic model. Finally, the nomogram model combining radscore and clinicopathologic characteristics was constructed. The performance of the three models was evaluated using receiver operating characteristic (ROC), calibration, and decision curve analyses (DCA). RESULTS: Totals of 21 radiomics features and five clinicopathologic characteristics were selected to develop the radscore and clinicopathological models. The radscore and clinicopathologic models achieved an area under the curve (AUC) of 0.752 and 0.600, respectively, in the training cohort; and of 0.723 and 0.615, respectively, in the validation cohort. The radiomics nomogram model showed improved discrimination efficiency compared with the radscore and clinicopathologic models, with an AUC of 0.773 and 0.740 in the training and validation cohorts, respectively. The calibration curve analysis and DCA showed favorable calibration and clinical utility of the nomogram model. CONCLUSIONS: The nomogram incorporating MRI-based radiomics features and clinicopathologic characteristics could be a potential tool for the prediction of MSI status in EC.
format Online
Article
Text
id pubmed-9816750
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-98167502023-01-07 Magnetic resonance-based radiomics nomogram for predicting microsatellite instability status in endometrial cancer Lin, Zijing Wang, Ting Li, Haiming Xiao, Meiling Ma, Xiaoliang Gu, Yajia Qiang, Jinwei Quant Imaging Med Surg Original Article BACKGROUND: Microsatellite instability (MSI) status is an important indicator for screening patients with endometrial cancer (EC) who have potential Lynch syndrome (LS) and may benefit from immunotherapy. This study aimed to develop a magnetic resonance imaging (MRI)-based radiomics nomogram for the prediction of MSI status in EC. METHODS: A total of 296 patients with histopathologically diagnosed EC were enrolled, and their MSI status was determined using immunohistochemical (IHC) analysis. Patients were randomly divided into the training cohort (n=236) and the validation cohort (n=60) at a ratio of 8:2. To predict the MSI status in EC, the tumor radiomics features were extracted from T2-weighted images and contrast-enhanced T1-weighted images, which in turn were selected using one-way analysis of variance (ANOVA) and the least absolute shrinkage and selection operator (LASSO) algorithm to build the radiomics signature (radiomics score; radscore) model. Five clinicopathologic characteristics were used to construct a clinicopathologic model. Finally, the nomogram model combining radscore and clinicopathologic characteristics was constructed. The performance of the three models was evaluated using receiver operating characteristic (ROC), calibration, and decision curve analyses (DCA). RESULTS: Totals of 21 radiomics features and five clinicopathologic characteristics were selected to develop the radscore and clinicopathological models. The radscore and clinicopathologic models achieved an area under the curve (AUC) of 0.752 and 0.600, respectively, in the training cohort; and of 0.723 and 0.615, respectively, in the validation cohort. The radiomics nomogram model showed improved discrimination efficiency compared with the radscore and clinicopathologic models, with an AUC of 0.773 and 0.740 in the training and validation cohorts, respectively. The calibration curve analysis and DCA showed favorable calibration and clinical utility of the nomogram model. CONCLUSIONS: The nomogram incorporating MRI-based radiomics features and clinicopathologic characteristics could be a potential tool for the prediction of MSI status in EC. AME Publishing Company 2022-10-19 2023-01-01 /pmc/articles/PMC9816750/ /pubmed/36620141 http://dx.doi.org/10.21037/qims-22-255 Text en 2023 Quantitative Imaging in Medicine and Surgery. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Lin, Zijing
Wang, Ting
Li, Haiming
Xiao, Meiling
Ma, Xiaoliang
Gu, Yajia
Qiang, Jinwei
Magnetic resonance-based radiomics nomogram for predicting microsatellite instability status in endometrial cancer
title Magnetic resonance-based radiomics nomogram for predicting microsatellite instability status in endometrial cancer
title_full Magnetic resonance-based radiomics nomogram for predicting microsatellite instability status in endometrial cancer
title_fullStr Magnetic resonance-based radiomics nomogram for predicting microsatellite instability status in endometrial cancer
title_full_unstemmed Magnetic resonance-based radiomics nomogram for predicting microsatellite instability status in endometrial cancer
title_short Magnetic resonance-based radiomics nomogram for predicting microsatellite instability status in endometrial cancer
title_sort magnetic resonance-based radiomics nomogram for predicting microsatellite instability status in endometrial cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816750/
https://www.ncbi.nlm.nih.gov/pubmed/36620141
http://dx.doi.org/10.21037/qims-22-255
work_keys_str_mv AT linzijing magneticresonancebasedradiomicsnomogramforpredictingmicrosatelliteinstabilitystatusinendometrialcancer
AT wangting magneticresonancebasedradiomicsnomogramforpredictingmicrosatelliteinstabilitystatusinendometrialcancer
AT lihaiming magneticresonancebasedradiomicsnomogramforpredictingmicrosatelliteinstabilitystatusinendometrialcancer
AT xiaomeiling magneticresonancebasedradiomicsnomogramforpredictingmicrosatelliteinstabilitystatusinendometrialcancer
AT maxiaoliang magneticresonancebasedradiomicsnomogramforpredictingmicrosatelliteinstabilitystatusinendometrialcancer
AT guyajia magneticresonancebasedradiomicsnomogramforpredictingmicrosatelliteinstabilitystatusinendometrialcancer
AT qiangjinwei magneticresonancebasedradiomicsnomogramforpredictingmicrosatelliteinstabilitystatusinendometrialcancer